Company Details
ambry-genetics
996
103,153
541714
ambrygen.com
0
AMB_3651356
In-progress

Ambry Genetics Company CyberSecurity Posture
ambrygen.comAmbry Genetics, a Tempus company, translates scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. It is a leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease. Its unparalleled track record of discoveries over 25 years, and growing database that continues to expand in collaboration with academic, corporate, and pharmaceutical partners, means Ambry Genetics is first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions. Hiring Fraud Alert: Ambry has received reports of employment scams in recent months that seek financial commitments, or requests personal information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) posing to be or represent Ambry recruiter(s). If you’ve experienced either of these scenarios, please visit this page to learn more about hiring fraud: https://consumer.ftc.gov/articles/job-scams. Or visit https://www.ambrygen.com/company/careers/recruitment-fraud-alert to learn more about our policy on recruitment fraud. You can confirm the legitimacy of a job posting by viewing our current open roles at https://ambrygen.com/careers.
Company Details
ambry-genetics
996
103,153
541714
ambrygen.com
0
AMB_3651356
In-progress
Between 700 and 749

Ambry Genetics Global Score (TPRM)XXXX

Description: The California Office of the Attorney General reported that Ambry Genetics Corporation experienced unauthorized access to an employee's email account between January 22-24, 2020. The incident may have involved personal information of affected individuals; however, the specific number of individuals impacted and the types of personal information compromised were not disclosed. The breach was reported on April 17, 2020.
Description: Ambry Genetics Corporation (“Ambry”) suffered a data breach incident in April 2020 after an employee’s email account was compromised. The breach compromised the Protected Health Information (“PHI”) and Personally Identifiable Information (“PII”) of approximately 225,370 patients. however, now after the settlement, Ambry has agreed to establish a $12,250,000 Settlement Fund to pay for credit monitoring services and identity theft insurance, cash payments to Class Members for reimbursement of certain out-of-pocket costs, an additional cash payment to Class Members who were a resident or citizen of California or Illinois sometime and the costs of the settlement administration, court-approved attorneys’ fees.


No incidents recorded for Ambry Genetics in 2025.
No incidents recorded for Ambry Genetics in 2025.
No incidents recorded for Ambry Genetics in 2025.
Ambry Genetics cyber incidents detection timeline including parent company and subsidiaries

Ambry Genetics, a Tempus company, translates scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. It is a leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease. Its unparalleled track record of discoveries over 25 years, and growing database that continues to expand in collaboration with academic, corporate, and pharmaceutical partners, means Ambry Genetics is first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions. Hiring Fraud Alert: Ambry has received reports of employment scams in recent months that seek financial commitments, or requests personal information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) posing to be or represent Ambry recruiter(s). If you’ve experienced either of these scenarios, please visit this page to learn more about hiring fraud: https://consumer.ftc.gov/articles/job-scams. Or visit https://www.ambrygen.com/company/careers/recruitment-fraud-alert to learn more about our policy on recruitment fraud. You can confirm the legitimacy of a job posting by viewing our current open roles at https://ambrygen.com/careers.

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr
Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to eva
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global heal
.png)
Shares of Tempus AI TEM gained 18.4% after it announced an agreement, on Nov. 4, 2024, to acquire Ambry Genetics for $600 million.
This Legal Update discusses recent cyber-litigation trends, notable data breach class-action litigation, and considerations for protecting privilege during a...
The average cost of a data breach is on the rise. According to the 2022 ForgeRock Consumer Identity Breach Report, the average cost in 2021...
Ambry Genetics agreed to a $12.25 million settlement to resolve claims a 2020 data breach compromised consumer data.
Ambry Genetics' email hack was one of the largest healthcare data breaches of 2020. The proposed filing will resolve claims the incident was...
The biggest healthcare data breaches in 2020 have been peppered with ransomware attacks, targeted, sophisticated phishing campaigns,...
Ambry Genetics has experienced an email security breach that affected almost 233000 individuals. Arizona Endocrinology Center has notified...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Ambry Genetics is https://www.ambrygen.com.
According to Rankiteo, Ambry Genetics’s AI-generated cybersecurity score is 724, reflecting their Moderate security posture.
According to Rankiteo, Ambry Genetics currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Ambry Genetics is not certified under SOC 2 Type 1.
According to Rankiteo, Ambry Genetics does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Ambry Genetics is not listed as GDPR compliant.
According to Rankiteo, Ambry Genetics does not currently maintain PCI DSS compliance.
According to Rankiteo, Ambry Genetics is not compliant with HIPAA regulations.
According to Rankiteo,Ambry Genetics is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Ambry Genetics operates primarily in the Biotechnology Research industry.
Ambry Genetics employs approximately 996 people worldwide.
Ambry Genetics presently has no subsidiaries across any sectors.
Ambry Genetics’s official LinkedIn profile has approximately 103,153 followers.
Ambry Genetics is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
No, Ambry Genetics does not have a profile on Crunchbase.
Yes, Ambry Genetics maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/ambry-genetics.
As of December 22, 2025, Rankiteo reports that Ambry Genetics has experienced 2 cybersecurity incidents.
Ambry Genetics has an estimated 4,514 peer or competitor companies worldwide.
Incident Types: The types of cybersecurity incidents that have occurred include Data Leak and Breach.
Title: Ambry Genetics Data Breach
Description: Ambry Genetics Corporation suffered a data breach incident in April 2020 after an employee’s email account was compromised. The breach compromised the Protected Health Information (PHI) and Personally Identifiable Information (PII) of approximately 225,370 patients. Ambry has agreed to establish a $12,250,000 Settlement Fund to pay for credit monitoring services and identity theft insurance, cash payments to Class Members for reimbursement of certain out-of-pocket costs, an additional cash payment to Class Members who were a resident or citizen of California or Illinois sometime, and the costs of the settlement administration, court-approved attorneys’ fees.
Date Detected: April 2020
Type: Data Breach
Attack Vector: Compromised Email Account
Vulnerability Exploited: Email Account Compromise
Title: Ambry Genetics Corporation Email Breach
Description: Unauthorized access to an employee's email account at Ambry Genetics Corporation between January 22-24, 2020, potentially involving personal information of affected individuals.
Date Detected: 2020-01-22
Date Publicly Disclosed: 2020-04-17
Type: Data Breach
Attack Vector: Email Compromise
Common Attack Types: The most common types of attacks the company has faced is Breach.
Identification of Attack Vectors: The company identifies the attack vectors used in incidents through Email Account Compromise.

Data Compromised: Phi, Pii
Legal Liabilities: Settlement Fund of $12,250,000
Identity Theft Risk: True

Data Compromised: Personal information
Systems Affected: Email Account
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are Phi, Pii, , Personal Information and .

Entity Name: Ambry Genetics Corporation
Entity Type: Corporation
Industry: Healthcare
Customers Affected: 225370

Entity Name: Ambry Genetics Corporation
Entity Type: Company
Industry: Genetics
Location: California

Type of Data Compromised: Phi, Pii
Number of Records Exposed: 225370
Sensitivity of Data: High

Type of Data Compromised: Personal information

Legal Actions: Settlement Fund
Ensuring Regulatory Compliance: The company ensures compliance with regulatory requirements through Settlement Fund.

Source: California Office of the Attorney General
Date Accessed: 2020-04-17
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: California Office of the Attorney GeneralDate Accessed: 2020-04-17.

Entry Point: Email Account Compromise

Root Causes: Email Account Compromise
Most Recent Incident Detected: The most recent incident detected was on April 2020.
Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on 2020-04-17.
Most Significant Data Compromised: The most significant data compromised in an incident were PHI, PII, , Personal Information and .
Most Significant System Affected: The most significant system affected in an incident was Email Account.
Most Sensitive Data Compromised: The most sensitive data compromised in a breach were PHI, PII and Personal Information.
Number of Records Exposed in Most Significant Breach: The number of records exposed in the most significant breach was 595.0.
Most Significant Legal Action: The most significant legal action taken for a regulatory violation was Settlement Fund.
Most Recent Source: The most recent source of information about an incident is California Office of the Attorney General.
Most Recent Entry Point: The most recent entry point used by an initial access broker was an Email Account Compromise.
.png)
A vulnerability has been found in SeaCMS up to 13.3. The affected element is an unknown function of the file js/player/dmplayer/dmku/class/mysqli.class.php. Such manipulation of the argument page/limit leads to sql injection. The attack can be executed remotely. The exploit has been disclosed to the public and may be used.
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in HappyDevs TempTool allows Stored XSS.This issue affects TempTool: from n/a through 1.3.1.
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Tormorten WP Microdata allows Stored XSS.This issue affects WP Microdata: from n/a through 1.0.
Exposure of Sensitive System Information to an Unauthorized Control Sphere vulnerability in HappyDevs TempTool allows Retrieve Embedded Sensitive Data.This issue affects TempTool: from n/a through 1.3.1.
A vulnerability has been found in Tenda FH1201 1.2.0.14(408). Affected is the function sprintf of the file /goform/SetIpBind. Such manipulation of the argument page leads to stack-based buffer overflow. The attack may be performed from remote. The exploit has been disclosed to the public and may be used.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.